$XCUR
Exicure Inc

2024 Q4 Form 10-Q Financial Statement

#000169853024000117 Filed on November 14, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development $0.00
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $2.572M
YoY Change -22.46%
Operating Profit -$2.572M
YoY Change -22.46%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $1.489M
YoY Change -176.79%
Pretax Income -$1.083M
YoY Change -79.39%
Income Tax $8.000K
% Of Pretax Income
Net Earnings -$1.091M
YoY Change -79.24%
Net Earnings / Revenue
Basic Earnings Per Share -$0.57
Diluted Earnings Per Share -$0.57
COMMON SHARES
Basic Shares Outstanding 2.172M shares 8.651M shares
Diluted Shares Outstanding 1.899M shares

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $343.0K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $2.600M
YoY Change -15.86%
LONG-TERM ASSETS
Property, Plant & Equipment $33.00K
YoY Change -45.9%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $2.072M
YoY Change -32.99%
Total Long-Term Assets $8.031M
YoY Change -18.55%
TOTAL ASSETS
Total Short-Term Assets $2.600M
Total Long-Term Assets $8.031M
Total Assets $10.63M
YoY Change -17.91%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.337M
YoY Change 54.57%
Accrued Expenses $2.318M
YoY Change 70.94%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.655M
YoY Change 64.57%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $3.655M
Total Long-Term Liabilities
Total Liabilities $9.086M
YoY Change 7.5%
SHAREHOLDERS EQUITY
Retained Earnings -$192.1M
YoY Change 2.13%
Common Stock $0.00
YoY Change -100.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.545M
YoY Change
Total Liabilities & Shareholders Equity $10.63M
YoY Change -17.91%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income -$1.091M
YoY Change -79.24%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
2572000 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
3317000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
3031000 usd
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Registrant Name
EntityRegistrantName
EXICURE, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
81-5333008
dei Entity Address Address Line1
EntityAddressAddressLine1
2430 N. Halsted St.
dei Entity Address City Or Town
EntityAddressCityOrTown
Chicago
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
60614
dei City Area Code
CityAreaCode
(847)
dei Local Phone Number
LocalPhoneNumber
673-1700
dei Security12b Title
Security12bTitle
Common Stock, par value $0.0001 per share
dei Trading Symbol
TradingSymbol
XCUR
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
816000 usd
dei Entity Address State Or Province
EntityAddressStateOrProvince
IL
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
907000 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
2600000 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
33000 usd
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
3655000 usd
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
5431000 usd
CY2024Q3 us-gaap Liabilities
Liabilities
9086000 usd
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2172323 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
0 usd
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
193628000 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-192083000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
1545000 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
10631000 usd
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1434000 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2397000 usd
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
0 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-600000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-1091000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-5256000 usd
us-gaap Net Income Loss
NetIncomeLoss
-2520000 usd
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
21000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
16000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
551000 usd
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2072000 usd
CY2024Q3 us-gaap Assets
Assets
10631000 usd
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1337000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
8549000 usd
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1832988 shares
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
0 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-293000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1457000 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-536000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9541000 usd
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
2000000 usd
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
343000 usd
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
50000 usd
CY2023Q4 us-gaap Other Receivables Gross Current
OtherReceivablesGrossCurrent
15000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1193000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
2024000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
54000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2985000 usd
CY2023Q4 us-gaap Assets
Assets
11580000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1631000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
6039000 usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
dei Entity File Number
EntityFileNumber
001-39011
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
0 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-189563000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
3031000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
11580000 usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
0 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
0 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1423000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4005000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11155000 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
192594000 usd
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.57
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.57
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.04
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.04
dei Document Type
DocumentType
10-Q
CY2023Q3 xcur Gain Loss On Disposition Of Assets Excluding Amount Included In Other Income Expense
GainLossOnDispositionOfAssetsExcludingAmountIncludedInOtherIncomeExpense
-920000 usd
xcur Gain Loss On Disposition Of Assets Excluding Amount Included In Other Income Expense
GainLossOnDispositionOfAssetsExcludingAmountIncludedInOtherIncomeExpense
0 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2985000 usd
CY2024Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
279000 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
279000 usd
CY2024Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
246000 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
225000 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
33000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
54000 usd
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
21000 usd
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
627000 usd
dei Entity Central Index Key
EntityCentralIndexKey
0001698530
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
2172323 shares
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
343000 usd
CY2024Q3 us-gaap Other Receivables Gross Current
OtherReceivablesGrossCurrent
1350000 usd
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
5926000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
6517000 usd
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2318000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
879000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2510000 usd
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1832988 shares
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-5256000 usd
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
500000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0 usd
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
500000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0 usd
xcur Variable Lease Cost Net
VariableLeaseCostNet
122000 usd
xcur Variable Lease Cost Net
VariableLeaseCostNet
545000 usd
CY2024Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
8000 usd
CY2023Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
0 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
28000 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
0 usd
CY2024Q3 us-gaap Lease Cost
LeaseCost
270000 usd
CY2023Q3 us-gaap Lease Cost
LeaseCost
284000 usd
us-gaap Lease Cost
LeaseCost
578000 usd
us-gaap Lease Cost
LeaseCost
1249000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
716000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
1379000 usd
CY2024Q3 us-gaap Sublease Income
SubleaseIncome
178000 usd
CY2023Q3 us-gaap Sublease Income
SubleaseIncome
179000 usd
us-gaap Sublease Income
SubleaseIncome
524000 usd
us-gaap Sublease Income
SubleaseIncome
179000 usd
CY2024Q3 us-gaap Sublease Income
SubleaseIncome
178000 usd
CY2023Q3 us-gaap Sublease Income
SubleaseIncome
179000 usd
us-gaap Sublease Income
SubleaseIncome
524000 usd
us-gaap Sublease Income
SubleaseIncome
179000 usd
CY2024Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.2
CY2024Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.2
CY2024Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.2
CY2024Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.2
CY2024Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.2
CY2024Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.2
CY2024Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.2
CY2022Q3 xcur Registration Rights Agreement Effective Period Following Closing Date
RegistrationRightsAgreementEffectivePeriodFollowingClosingDate
P2Y
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2172323 shares
CY2024Q3 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
1138000 usd
CY2023Q3 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
0 usd
us-gaap Litigation Settlement Expense
LitigationSettlementExpense
1138000 usd
us-gaap Litigation Settlement Expense
LitigationSettlementExpense
0 usd
CY2024Q3 xcur Gain Loss On Disposition Of Assets Excluding Amount Included In Other Income Expense
GainLossOnDispositionOfAssetsExcludingAmountIncludedInOtherIncomeExpense
0 usd
xcur Gain Loss On Disposition Of Assets Excluding Amount Included In Other Income Expense
GainLossOnDispositionOfAssetsExcludingAmountIncludedInOtherIncomeExpense
-920000 usd
us-gaap Operating Expenses
OperatingExpenses
5143000 usd
us-gaap Operating Expenses
OperatingExpenses
13498000 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2572000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-3317000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-4643000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-13498000 usd
CY2024Q3 xcur Changes In Fair Value Of Investment In Convertible Notes Receivable
ChangesInFairValueOfInvestmentInConvertibleNotesReceivable
0 usd
CY2023Q3 xcur Changes In Fair Value Of Investment In Convertible Notes Receivable
ChangesInFairValueOfInvestmentInConvertibleNotesReceivable
2000000 usd
xcur Changes In Fair Value Of Investment In Convertible Notes Receivable
ChangesInFairValueOfInvestmentInConvertibleNotesReceivable
0 usd
xcur Changes In Fair Value Of Investment In Convertible Notes Receivable
ChangesInFairValueOfInvestmentInConvertibleNotesReceivable
2000000 usd
CY2024Q3 us-gaap Investment Income Dividend
InvestmentIncomeDividend
0 usd
CY2023Q3 us-gaap Investment Income Dividend
InvestmentIncomeDividend
13000 usd
us-gaap Investment Income Dividend
InvestmentIncomeDividend
5000 usd
us-gaap Investment Income Dividend
InvestmentIncomeDividend
45000 usd
CY2024Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
1000 usd
CY2023Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
4000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
7000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
28000 usd
CY2024Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
12000 usd
CY2023Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
0 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
18000 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
0 usd
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1500000 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
44000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2137000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2000 usd
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1489000 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1939000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2131000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1929000 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1083000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5256000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2512000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-15427000 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-1091000 usd
us-gaap Net Income Loss
NetIncomeLoss
-2520000 usd
us-gaap Net Income Loss
NetIncomeLoss
-15427000 usd
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.36
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.36
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-9.89
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-9.89
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1899412 shares
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1899412 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1730104 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1730104 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1855286 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1855286 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1559868 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1559868 shares
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-829000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
2207000 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
1613000 usd
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5000 usd
CY2024Q3 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
1018000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
1545000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
14922000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
308000 usd
CY2023Q1 xcur Adjustments To Additional Paid In Capital Decrease Related To Reclassification
AdjustmentsToAdditionalPaidInCapitalDecreaseRelatedToReclassification
800000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-1000 usd
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
4597000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-4407000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
14619000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
969000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-119000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-5764000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
9705000 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
50000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-1000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
4498000 usd
us-gaap Net Income Loss
NetIncomeLoss
-15427000 usd
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
627000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1327000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
591000 usd
xcur Changes In Fair Value Of Investment In Convertible Notes Receivable
ChangesInFairValueOfInvestmentInConvertibleNotesReceivable
0 usd
xcur Changes In Fair Value Of Investment In Convertible Notes Receivable
ChangesInFairValueOfInvestmentInConvertibleNotesReceivable
2000000 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-920000 usd
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
1335000 usd
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
0 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-607000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-124000 usd
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-291000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
504000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
78000 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-609000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2065000 usd
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
0 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
211000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1789000 usd
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
1000000 usd
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
0 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
5440000 usd
xcur Payments Of Common Stock Financing Costs
PaymentsOfCommonStockFinancingCosts
0 usd
xcur Payments Of Common Stock Financing Costs
PaymentsOfCommonStockFinancingCosts
843000 usd
xcur Payment For Exercise Of Common Stock Warrant
PaymentForExerciseOfCommonStockWarrant
0 usd
xcur Payment For Exercise Of Common Stock Warrant
PaymentForExerciseOfCommonStockWarrant
800000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
122000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1000000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3675000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1065000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-7655000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2016000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9777000 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
951000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2122000 usd
xcur Increase Decrease In Other Receivables Noncash
IncreaseDecreaseInOtherReceivablesNoncash
0 usd
xcur Increase Decrease In Other Receivables Noncash
IncreaseDecreaseInOtherReceivablesNoncash
711000 usd
xcur Equity Effect Of Debt To Equity Conversion
EquityEffectOfDebtToEquityConversion
1018000 usd
xcur Equity Effect Of Debt To Equity Conversion
EquityEffectOfDebtToEquityConversion
0 usd
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
343000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
816000 usd
CY2024Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
608000 usd
CY2023Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
1200000 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
951000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2016000 usd
CY2024Q3 xcur Stock Issued During Period Shares Reverse Stock Splits Fractional Share Roundups
StockIssuedDuringPeriodSharesReverseStockSplitsFractionalShareRoundups
102837 shares
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div>The preparation of the financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Management bases its estimates on certain assumptions which it believes are reasonable in the circumstances and while actual results could differ from those estimates, management does not believe that any change in those assumptions in the near term would have a significant effect on the Company’s financial position, results of operations or cash flows. Actual results in future periods could differ from those estimates.
CY2024Q3 us-gaap Prepaid Insurance
PrepaidInsurance
455000 usd
CY2023Q4 us-gaap Prepaid Insurance
PrepaidInsurance
508000 usd
CY2024Q3 xcur Prepaid Franchise Tax
PrepaidFranchiseTax
28000 usd
CY2023Q4 xcur Prepaid Franchise Tax
PrepaidFranchiseTax
259000 usd
CY2024Q3 xcur Lease Cost Current
LeaseCostCurrent
260000 usd
CY2023Q4 xcur Lease Cost Current
LeaseCostCurrent
235000 usd
CY2024Q3 xcur Prepaid Professional Fees Current
PrepaidProfessionalFeesCurrent
70000 usd
CY2023Q4 xcur Prepaid Professional Fees Current
PrepaidProfessionalFeesCurrent
95000 usd
CY2024Q3 xcur Prepaid Software Current
PrepaidSoftwareCurrent
46000 usd
CY2023Q4 xcur Prepaid Software Current
PrepaidSoftwareCurrent
72000 usd
CY2024Q3 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
48000 usd
CY2023Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
24000 usd
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
907000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1193000 usd
CY2024Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
608000 usd
CY2023Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
1200000 usd
CY2024Q3 xcur Prepaid Insurance Noncurrent
PrepaidInsuranceNoncurrent
1464000 usd
CY2023Q4 xcur Prepaid Insurance Noncurrent
PrepaidInsuranceNoncurrent
1785000 usd
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2072000 usd
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
697000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
626000 usd
CY2024Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
0 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
71000 usd
CY2024Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
267000 usd
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
34000 usd
CY2024Q3 us-gaap Loss Contingency Accrual Carrying Value Current
LossContingencyAccrualCarryingValueCurrent
1138000 usd
CY2023Q4 us-gaap Loss Contingency Accrual Carrying Value Current
LossContingencyAccrualCarryingValueCurrent
0 usd
CY2024Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
216000 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
148000 usd
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2318000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
879000 usd
CY2024Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
143000 usd
CY2023Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
52000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
428000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
704000 usd
CY2024Q3 xcur Variable Lease Cost Net
VariableLeaseCostNet
119000 usd
CY2023Q3 xcur Variable Lease Cost Net
VariableLeaseCostNet
232000 usd
CY2024Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
0 usd
CY2023Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
0 usd
CY2024Q3 xcur Debt Instrument Number Of Exchange Agreements Executed
DebtInstrumentNumberOfExchangeAgreementsExecuted
2 agreement
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2172323 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2172323 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1832988 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1832988 shares
CY2024Q3 xcur Common Stock Voting Rights For Each Share
CommonStockVotingRightsForEachShare
1 vote
CY2022Q3 xcur Registration Rights Agreement Required Filing Term
RegistrationRightsAgreementRequiredFilingTerm
P90D
CY2022Q3 xcur Registration Rights Agreement Liquidation Damages Payable As A Percent Of Amount Invested If Filed Late
RegistrationRightsAgreementLiquidationDamagesPayableAsAPercentOfAmountInvestedIfFiledLate
0.005
CY2022Q3 xcur Registration Rights Agreement Liquidation Damages Payable If Filed Late Measurement Term
RegistrationRightsAgreementLiquidationDamagesPayableIfFiledLateMeasurementTerm
P30D
CY2021Q4 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P5Y
CY2021Q4 xcur Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
11478000 usd
CY2021Q4 xcur Proceeds From Issuance Of Common Stock And Warrants Net Of Placement Agent Fee And Other Offering Expenses Payable
ProceedsFromIssuanceOfCommonStockAndWarrantsNetOfPlacementAgentFeeAndOtherOfferingExpensesPayable
10226000 usd
CY2021Q4 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P5Y
CY2021Q4 xcur Class Of Warrant Or Right Ownership Percentage Limitation
ClassOfWarrantOrRightOwnershipPercentageLimitation
0.0499
CY2021Q4 xcur Class Of Warrant Or Right Ownership Percentage Limitation At Election Of Purchaser
ClassOfWarrantOrRightOwnershipPercentageLimitationAtElectionOfPurchaser
0.0999
CY2021Q4 xcur Class Of Warrant Or Right Ownership Percentage Limitation
ClassOfWarrantOrRightOwnershipPercentageLimitation
0.0499
CY2021Q4 xcur Class Of Warrant Or Right Ownership Percentage Limitation At Election Of Purchaser
ClassOfWarrantOrRightOwnershipPercentageLimitationAtElectionOfPurchaser
0.0999
CY2021Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
115253 shares
CY2021Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
40.5155
CY2023Q1 xcur Class Of Warrant Or Right Warrant Exercised Period Before Closing
ClassOfWarrantOrRightWarrantExercisedPeriodBeforeClosing
P30D
CY2023Q2 xcur Class Of Warrant Or Right Payment For Liability
ClassOfWarrantOrRightPaymentForLiability
800000 usd
CY2023Q2 xcur Class Of Warrant Or Right Number Of Securities Settled In Period
ClassOfWarrantOrRightNumberOfSecuritiesSettledInPeriod
105231 shares
CY2024Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
10022 shares
CY2024Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
40.5155
CY2024Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
16000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1327000 usd
CY2024Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
16000 usd
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y1M6D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0383
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0383
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
1.009
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
1.009
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
1.009
xcur Sharebased Compensation Arrangementby Sharebased Payment Award Fair Value Assumptions Forfeiture Rate
SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsForfeitureRate
0.05
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2023Q3 us-gaap Share Price
SharePrice
7.90
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
7.90
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
6.30
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2427 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
21.40
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y4M24D
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
0 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
84 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
27.55
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2343 shares
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
27.55
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y7M6D
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
0 usd
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2343 shares
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
27.55
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y7M6D
CY2024Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0 usd
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
2343 shares
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
27.55
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P4Y7M6D
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-1091000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-5256000 usd
us-gaap Net Income Loss
NetIncomeLoss
-2520000 usd
us-gaap Net Income Loss
NetIncomeLoss
-15427000 usd
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1899412 shares
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1899412 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1730104 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1730104 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1855286 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1855286 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1559868 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1559868 shares
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.57
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.57
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.04
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.04
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.36
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.36
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-9.89
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-9.89
CY2024Q3 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
1140000 usd
CY2024Q3 xcur Loss Contingency Self Insured Retention Retainer Amount
LossContingencySelfInsuredRetentionRetainerAmount
2500000 usd
CY2024Q3 xcur Sale Of Productive Assets Expected Consideration
SaleOfProductiveAssetsExpectedConsideration
1500000 usd
CY2024Q3 xcur Purchase Agreement Royalties And License Fee Entitlement Period
PurchaseAgreementRoyaltiesAndLicenseFeeEntitlementPeriod
P10Y
CY2024Q3 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
150000 usd
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0001698530-24-000117-index-headers.html Edgar Link pending
0001698530-24-000117-index.html Edgar Link pending
0001698530-24-000117.txt Edgar Link pending
0001698530-24-000117-xbrl.zip Edgar Link pending
exicureexhibit101.htm Edgar Link pending
exicureexhibit311-93024.htm Edgar Link pending
exicureexhibit312-93024.htm Edgar Link pending
exicureexhibit321-93024.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
xcur-20240930.htm Edgar Link pending
xcur-20240930.xsd Edgar Link pending
xcur-20240930_cal.xml Edgar Link unprocessable
xcur-20240930_def.xml Edgar Link unprocessable
xcur-20240930_lab.xml Edgar Link unprocessable
xcur-20240930_pre.xml Edgar Link unprocessable
xcur-20240930_htm.xml Edgar Link completed